Medicare PDGM Explained for Home Health Agencies: Maximize Reimbursement Under the New Model
Learn how Medicare PDGM works for home health agencies, including payment variables, reimbursement calculation, LUPA thresholds, documentation requirements, and strategies to maximize revenue under the PDGM model.
KNOWLEDGE CENTER
5/19/20264 min read
The Patient-Driven Groupings Model (PDGM) represents one of the most transformative reimbursement changes ever implemented in the U.S. home health industry. Introduced by the Centers for Medicare & Medicaid Services (CMS) in January 2020, PDGM fundamentally shifted Medicare home health payments away from therapy-driven volume and toward patient clinical complexity, diagnosis, and functional status.
For agencies that previously relied on therapy utilization to drive revenue, PDGM required a complete redesign of operational, clinical, and documentation workflows. For agencies that adapted effectively, PDGM created opportunities for more accurate reimbursement, stronger clinical documentation, improved patient stratification, and better alignment with value-based care models.
Today, PDGM is not just a reimbursement system—it is a clinical payment framework that directly ties revenue to patient characteristics and care needs.
This guide provides a comprehensive 1800+ word breakdown of PDGM, including:
What PDGM is and why CMS implemented it
The six core payment variables
How episode grouping works
LUPA thresholds and implications
Functional impairment scoring
Comorbidity adjustments
Documentation requirements under CMS rules
Common compliance risks and audit triggers
Strategies to maximize reimbursement legally and compliantly
Operational impacts on home health agencies
1. What Is PDGM?
The Patient-Driven Groupings Model (PDGM) is the Medicare payment methodology for home health services under the Home Health Prospective Payment System (HH PPS).
Under PDGM:
Medicare pays home health agencies based on patient characteristics rather than the number of therapy visits provided.
Each episode of care is:
30 days in length (instead of 60 days under the old system)
Case-mix adjusted based on clinical and functional factors
Subject to different payment weights depending on patient complexity
2. Why CMS Implemented PDGM
Before PDGM, Medicare used a therapy-driven payment model where:
Higher therapy visit counts resulted in higher reimbursement
Agencies had incentives to increase therapy utilization
Payment was less reflective of patient clinical complexity
CMS implemented PDGM to:
Reduce therapy overutilization incentives
Improve payment accuracy based on patient need
Strengthen program integrity and reduce fraud risk
Align home health with value-based care principles
Improve clinical documentation quality
3. PDGM Episode Structure
Under PDGM:
Each billing episode is 30 days
Agencies may bill multiple consecutive 30-day periods
Each period is independently evaluated and reimbursed
This means:
A patient can generate multiple payment cycles based on ongoing need for home health services.
4. The 6 Key PDGM Payment Variables
PDGM determines reimbursement using six core variables.
4.1 Admission Source
There are two categories:
Community Admission
Patient has not been in an inpatient facility within 14 days prior to SOC
Generally lower reimbursement
Institutional Admission
Patient discharged from hospital, skilled nursing facility, or rehab facility within 14 days
Higher reimbursement due to higher acuity
Why it matters:
Institutional admissions reflect more complex post-acute needs, increasing expected resource utilization.
4.2 Timing (Early vs Late Episode)
PDGM distinguishes:
Early episodes (1st or 2nd 30-day period)
Late episodes (3rd or later)
Key impact:
Early episodes generally receive higher reimbursement
Late episodes assume stabilization and reduced resource needs
4.3 Clinical Grouping
Patients are categorized into 12 clinical groups based on primary diagnosis.
Examples include:
Musculoskeletal rehabilitation
Neuro/stroke rehabilitation
Wound care
Complex nursing intervention
Cardiac/circulatory conditions
Respiratory conditions
Behavioral health
Infectious disease management
Key principle:
Diagnosis drives payment—not therapy volume.
4.4 Functional Impairment Level
Patients are categorized as:
Low
Medium
High
Based on:
ADL dependency
Mobility limitations
Cognitive impairment
Self-care ability
Impact:
Higher functional impairment = higher reimbursement.
4.5 Comorbidity Adjustment
CMS evaluates secondary diagnoses to determine resource intensity.
Categories include:
No comorbidity adjustment
Low comorbidity adjustment
High comorbidity adjustment
Example:
A patient with CHF + diabetes + chronic kidney disease will likely receive higher reimbursement than a patient with a single diagnosis.
4.6 LUPA Threshold (Low Utilization Payment Adjustment)
Each case-mix group has a LUPA threshold, which is the minimum number of visits required to receive full episode payment.
If visits fall below threshold:
Agency is paid per visit instead of full episode rate.
Typical thresholds range from 2–6 visits depending on case mix.
5. PDGM Payment Logic (Simplified)
PDGM reimbursement is calculated based on:
Base rate × (Admission Source factor + Clinical Group weight + Functional level + Comorbidity adjustment)
Then adjusted for:
Wage index
Sequestration
LUPA status
6. Documentation Requirements Under PDGM
PDGM is highly dependent on accurate clinical documentation.
6.1 OASIS Assessment Accuracy
OASIS drives:
Functional impairment level
Case-mix assignment
Payment calculation
Errors in OASIS directly affect reimbursement.
6.2 Diagnosis Documentation
Agencies must ensure:
Primary diagnosis is clinically supported
ICD-10 coding reflects true patient condition
Secondary diagnoses are properly documented
6.3 Skilled Need Justification
Documentation must clearly show:
Why skilled care is necessary
Why services cannot be delegated
Why home health is appropriate
6.4 Functional Scoring Support
Clinical notes must support:
ADL dependency
Mobility status
Cognitive impairment
Inconsistencies between OASIS and visit notes are a major audit risk.
6.5 Visit Documentation
Each visit note must include:
Skilled interventions provided
Patient response
Progress toward goals
Any changes in condition
7. Common PDGM Compliance Risks
7.1 Diagnosis Misclassification
Incorrect primary diagnosis assignment
Unsupported coding selection
7.2 OASIS Scoring Errors
Overstating or understating functional impairment
Inconsistent documentation across disciplines
7.3 LUPA Failures
Not meeting visit thresholds
Poor early scheduling after SOC
7.4 Upcoding Risk
Inflating comorbidity levels
Artificially increasing functional impairment scores
7.5 Incomplete Documentation
Missing skilled justification
Weak narrative support for ongoing care
8. Strategies to Maximize PDGM Reimbursement (Compliantly)
8.1 Improve OASIS Accuracy
Invest in OASIS training for clinicians
Implement internal QA review processes
Standardize assessment workflows
8.2 Optimize Admission Source Identification
Ensure hospital discharge status is accurately captured
Verify 14-day inpatient rule documentation
8.3 Strengthen Diagnosis Capture
Use full clinical documentation to support ICD-10 coding
Ensure physician documentation aligns with agency coding
8.4 Reduce LUPA Episodes
Schedule early visits after SOC
Implement proactive visit planning
Monitor high-risk patients
8.5 Improve Functional Documentation
Standardize ADL scoring tools
Ensure consistency across disciplines
Avoid documentation gaps between nurse and therapy notes
8.6 Strengthen Interdisciplinary Coordination
Regular case conferences
Communication between RN, PT, OT, and SW
Unified care planning approach
9. Operational Impact of PDGM
PDGM significantly changed home health operations.
9.1 Shift from Volume to Complexity
Therapy volume is no longer the primary revenue driver. Instead:
Clinical complexity matters most
Chronic disease management is prioritized
9.2 Increased Documentation Burden
Agencies must now:
Improve clinical narratives
Strengthen OASIS accuracy
Maintain consistent care plans
9.3 Higher Audit Risk Environment
PDGM increased scrutiny from:
Medicare Administrative Contractors (MACs)
RAC audits
UPIC investigations
9.4 Revenue Variability
Revenue is now more sensitive to:
Admission accuracy
Functional scoring
Diagnosis selection
10. PDGM and Value-Based Care Alignment
PDGM is a foundation for:
Home Health Value-Based Purchasing (HHVBP)
ACO participation
Bundled payment models
Agencies that perform well under PDGM are better positioned for:
Quality incentive payments
Shared savings models
Preferred network inclusion
Conclusion
The Medicare PDGM model represents a structural shift in home health reimbursement from a therapy-driven system to a patient-centered, clinically driven payment model. Success under PDGM requires agencies to master:
OASIS accuracy
ICD-10 coding precision
Functional impairment documentation
Admission source identification
LUPA prevention strategies
Interdisciplinary coordination
Agencies that adapt effectively to PDGM not only improve reimbursement accuracy but also strengthen clinical quality, reduce audit exposure, and position themselves for future value-based care opportunities.
However, agencies that fail to adapt face risks of revenue loss, compliance deficiencies, and increased audit scrutiny.
For home health organizations seeking PDGM optimization, OASIS training, coding audits, compliance system development, and reimbursement strategy support, consulting firms such as HealthBridge Consulting are commonly engaged to improve financial and operational performance.
References

Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.
The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.
HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws.
© 2026 HealthBridge US, a California corporation. All rights reserved.
For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance
Legal
Resources
Based in Los Angeles, California, operating in all 50 states.












